Skip to main content
Clinical Trials/IRCT20180205038626N15
IRCT20180205038626N15
Recruiting
Phase 3

Comparison of the effect of oral and intravenous iron supplementation on quality of life and function of patients with heart failure: a randomized clinical trial

Rasht University of Medical Sciences0 sites180 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Rasht University of Medical Sciences
Enrollment
180
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Rasht University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Patients with heart failure
  • Age above 18 years
  • Serum ferritin levels \<100 or TS \<20%
  • Ferritin 100\-300 and hemoglobin below 15

Exclusion Criteria

  • Known and treated anemia
  • Allergy or intolerance to iron supplements
  • Duodenal or gastric ulcer, gastrointestinal disease with impaired iron absorption
  • Oncological diseases
  • History of surgery 6 months before entering the study
  • Active bleeding and the need for blood transfusion in patients with shock or sepsis
  • Unwillingness to continue the study or cause any dissatisfaction in the field of taking iron supplements or participating in the study
  • Acute heart failure

Outcomes

Primary Outcomes

Not specified

Similar Trials